How to develop a meaningful radiomic signature for clinical use in oncologic patients

• Published in: Cancer imaging Vol. 20; no. 1; pp. 33 - 10
• Main Authors: Papanikolaou, Nikolaos, Matos, Celso, Koh, Dow Mu
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 01.05.2020; BioMed Central; BMC
• Subjects: Biomarkers; Biopsy; Cancer therapies; Classification; Diagnostic systems; Disease; Documents; Humans; Image Interpretation, Computer-Assisted - methods; Image Processing, Computer-Assisted - methods; Ionizing radiation; Machine Learning; Medical imaging; Medical imaging equipment; Methods; Neoplasms - diagnostic imaging; New technology; Patients; Practice Guidelines as Topic; Precision medicine; Quantitative analysis; Quantitative imaging; Radiology; Radiomics; Review; Tumors; Workflow; Quantitative imaging; Machine learning; Radiomics
• ISSN: 1470-7330; 1740-5025; 1470-7330
• DOI: 10.1186/s40644-020-00311-4

During the last decade, there is an increasing usage of quantitative methods in Radiology in an effort to reduce the diagnostic variability associated with a subjective manner of radiological interpretation. Combined approaches where visual assessment made by the radiologist is augmented by quantitative imaging biomarkers are gaining attention. Advances in machine learning resulted in the rise of radiomics that is a new methodology referring to the extraction of quantitative information from medical images. Radiomics are based on the development of computational models, referred to as “Radiomic Signatures”, trying to address either unmet clinical needs, mostly in the field of oncologic imaging, or to compare radiomics performance with that of radiologists. However, to explore this new technology, initial publications did not consider best practices in the field of machine learning resulting in publications with questionable clinical value. In this paper, our effort was concentrated on how to avoid methodological mistakes and consider critical issues in the workflow of the development of clinically meaningful radiomic signatures.